MKI67 and neoplasm: Higher patient age (median 47.50 vs 29, P = .01, Mann‐Whitney test), a smaller tumour diameter (average 20.08 mm ± SD 6.94 vs 34.23 mm ± SD 7.55, P = .002, Student's t‐test),tumour volume (median 2227.7 mm3 vs 12 184.7 mm3 , P = .002, Mann‐Whitney test), lower proliferative activity evaluated by Ki67 index (average 2.039 ± SD 1.43 vs 4.36 ± SD 0.89, P = .004, Student's t‐test), and higher expression of SSTR2A (average 137.50 ± SD 76.93 vs 55.88 ± S.D 65.08, P = .038, Student's t‐test) all proved to be positive predictors of the therapeutic response in the SGST subgroup.